Drug Discovery
-
High activity,
High selectivity -
High permeability,
Low system residue -
Local precision
drug delivery
Product Pipeline
|
Stage |
Project |
Indications |
Preclinical |
IND |
Clinical phase Ia |
Clinical phase Ib/II |
Clinical phase III |
| Clinical stage | QY201 |
 |
|||||
| QY201 |
 |
||||||
| QY211 |
 |
||||||
| QY101 |
 |
||||||
| Preclinical stage | QY301 |
 |
- Clinical stage
- IND stage
- Preclinical stage
